argenx SE (ARGX)

892.16 -5.69 (-0.63%) USD  |  NASDAQ  |  Oct 30, 16:00
898.99 +6.83 (+0.77%) After-Hours: 20:00
More

argenx Cash from Operations (Quarterly)

Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2014 0.3306M
Date Value
March 31, 2014 -3.157M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Autolus Therapeutics Plc -25.16M
Cellectis SA -14.34M
Akari Therapeutics Plc -3.112M
DBV Technologies SA -51.47M
Halozyme Therapeutics, Inc. 240.89M

Cash from Operations (Quarterly) Related Metrics

Free Cash Flow 1.090B
Free Cash Flow Yield 1.87%